<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0006744'>Adrenocortical carcinomas</z:hpo> are rare in children and sometimes occur in patients with predisposing syndrome like Li-Fraumeni or <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndromes</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The diagnosis is often based on clinical, biological and radiological findings completed by histological examination </plain></SENT>
<SENT sid="2" pm="."><plain>The gold standard of treatment remains radical surgery sometimes completed by a cytotoxic chemotherapy based on <z:chebi fb="240" ids="33364,33400">platinum</z:chebi>-derived drugs, <z:chebi fb="0" ids="4911">etoposide</z:chebi> and <z:chebi fb="0" ids="28748">doxorubicin</z:chebi>, in association with mitotane in case of high risk of relapse </plain></SENT>
<SENT sid="3" pm="."><plain>The role of radiation therapy is discussed because of the relatively frequent involvement of p53 mutations </plain></SENT>
<SENT sid="4" pm="."><plain>The rarity of this type of disease and the poor prognosis of the locally advanced and metastatic forms must lead to the systematic registration of these patients and to the harmonization of the management in a national or even European level </plain></SENT>
</text></document>